Viridian Therapeutics, Inc./DE Weighted Average Number of Shares Outstanding, Basic and Diluted
Viridian Therapeutics, Inc./DE (VRDN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 6.34 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-07.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-07
- Viridian Therapeutics, Inc./DE weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 6.34M shares, a 109.00% increase year-over-year.
- Viridian Therapeutics, Inc./DE weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was -140.16M shares.
- Viridian Therapeutics, Inc./DE weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 55.79M shares, a 79.49% increase year-over-year.
- Viridian Therapeutics, Inc./DE weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 53.08M shares, a 71.31% increase year-over-year.
- Viridian Therapeutics, Inc./DE weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 3.56M shares, a 70.27% increase from fiscal 2019.
- Viridian Therapeutics, Inc./DE weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 2.09M shares, a 92.94% decline from fiscal 2018.
- Viridian Therapeutics, Inc./DE weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 29.60M shares, a 53.81% increase from fiscal 2017.
- Viridian Therapeutics, Inc./DE weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 19.24M shares, a 3034.21% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-03-31 | 6.34M shares 10-Q · filed 2021-05-07 | -66.91M shares derived: average of 2 quarters · filed 2021-05-07 | -26.01M shares derived: average of 3 quarters · filed 2021-05-07 | -6.24M shares derived: average of 4 quarters · filed 2021-05-07 | ||||
| 2020-12-31 | -140.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -42.19M shares derived: average of 2 quarters · filed 2021-03-26 | -10.43M shares derived: average of 3 quarters · filed 2021-03-26 | 3.56M shares 10-K · filed 2021-03-26 | ||||
| 2020-09-30 | 55.79M shares 10-Q · filed 2020-11-12 | 54.43M shares derived: average of 2 quarters · filed 2020-11-12 | 51.46M shares 10-Q · filed 2020-11-12 | 6.82M shares derived: average of 4 quarters · filed 2021-05-07 | ||||
| 2020-06-30 | 53.08M shares 10-Q · filed 2020-08-05 | 49.28M shares 10-Q · filed 2020-08-05 | -9.50M shares derived: average of 3 quarters · filed 2021-05-07 | 648.33K shares derived: average of 4 quarters · filed 2021-05-07 | ||||
| 2020-03-31 | 3.03M shares 10-Q · filed 2021-05-07 | 45.48M shares 10-Q · filed 2020-05-08 | -40.78M shares derived: average of 2 quarters · filed 2021-05-07 | -16.83M shares derived: average of 3 quarters · filed 2021-05-07 | -4.88M shares derived: average of 4 quarters · filed 2021-05-07 | |||
| 2019-12-31 | -84.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -26.76M shares derived: average of 2 quarters · filed 2021-03-26 | -7.51M shares derived: average of 3 quarters · filed 2021-03-26 | 2.09M shares 10-K · filed 2021-03-26 | 31.34M shares 10-K · filed 2020-03-13 | |||
| 2019-09-30 | 31.08M shares 10-Q · filed 2020-11-12 | 31.03M shares derived: average of 2 quarters · filed 2020-11-12 | 30.98M shares 10-Q · filed 2020-11-12 | 30.95M shares derived: average of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | 30.98M shares 10-Q · filed 2020-08-05 | 30.94M shares 10-Q · filed 2020-08-05 | 30.91M shares derived: average of 3 quarters · filed 2020-08-05 | 30.86M shares derived: average of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | 30.89M shares 10-Q · filed 2020-05-08 | 30.87M shares derived: average of 2 quarters · filed 2020-05-08 | 30.82M shares derived: average of 3 quarters · filed 2020-05-08 | 30.69M shares derived: average of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | 30.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 30.79M shares derived: average of 2 quarters · filed 2020-03-13 | 30.62M shares derived: average of 3 quarters · filed 2020-03-13 | 29.60M shares 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | 30.72M shares 10-Q · filed 2019-11-08 | 30.51M shares derived: average of 2 quarters · filed 2019-11-08 | 29.18M shares 10-Q · filed 2019-11-08 | 27.46M shares derived: average of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | 30.30M shares 10-Q · filed 2019-08-08 | 28.40M shares 10-Q · filed 2019-08-08 | 26.37M shares derived: average of 3 quarters · filed 2019-08-08 | 25.17M shares derived: average of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | 26.48M shares 10-Q · filed 2019-05-09 | 24.41M shares derived: average of 2 quarters · filed 2019-05-09 | 23.46M shares derived: average of 3 quarters · filed 2019-05-09 | 22.95M shares derived: average of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | 22.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | 21.95M shares derived: average of 2 quarters · filed 2019-03-14 | 21.77M shares derived: average of 3 quarters · filed 2019-03-14 | 19.24M shares 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | 21.57M shares 10-Q · filed 2018-11-07 | 21.49M shares derived: average of 2 quarters · filed 2018-11-07 | 18.22M shares 10-Q · filed 2018-11-07 | 13.80M shares derived: average of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | 21.41M shares 10-Q · filed 2018-08-08 | 16.51M shares 10-Q · filed 2018-08-08 | 11.21M shares derived: average of 3 quarters · filed 2018-08-08 | 8.55M shares derived: average of 4 quarters · filed 2018-08-08 | ||||
| 2017-03-31 | 11.56M shares 10-Q · filed 2018-05-09 | 6.10M shares derived: average of 2 quarters · filed 2018-05-09 | 4.27M shares derived: average of 3 quarters · filed 2018-05-09 | 3.35M shares derived: average of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | 651.07K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | 626.37K shares derived: average of 2 quarters · filed 2018-03-15 | 618.13K shares derived: average of 3 quarters · filed 2018-03-15 | 614.02K shares 10-K · filed 2018-03-15 | 721.41K shares 10-K · filed 2017-03-24 | |||
| 2016-09-30 | 601.67K shares 10-Q · filed 2017-11-09 | 10.79M shares 10-Q · filed 2016-10-26 | 601.67K shares derived: average of 2 quarters · filed 2017-11-09 | 601.67K shares 10-Q · filed 2017-11-09 | 10.75M shares 10-Q · filed 2016-10-26 | -4.42M shares derived: average of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | 601.67K shares 10-Q · filed 2017-08-11 | 10.73M shares 10-Q · filed 2016-08-15 | 601.67K shares 10-Q · filed 2017-08-11 | 10.74M shares 10-Q · filed 2016-08-15 | -6.10M shares derived: average of 3 quarters · filed 2017-08-11 | -2.54M shares derived: average of 4 quarters · filed 2017-08-11 | ||
| 2016-03-31 | 651.04K shares 10-Q · filed 2017-05-11 | 10.74M shares 10-Q · filed 2016-05-16 | -9.45M shares derived: average of 2 quarters · filed 2017-05-11 | -3.59M shares derived: average of 3 quarters · filed 2017-05-11 | -746.05K shares derived: average of 4 quarters · filed 2017-05-11 | |||
| 2015-12-31 | -19.55M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | -5.71M shares derived: average of 2 quarters · filed 2017-03-24 | -1.21M shares derived: average of 3 quarters · filed 2017-03-24 | 539.46K shares 10-K · filed 2017-03-24 | 8.09M shares 10-K · filed 2016-03-21 | |||
| 2015-09-30 | 8.13M shares 10-Q · filed 2016-10-26 | 7.96M shares derived: average of 2 quarters · filed 2016-10-26 | 7.23M shares 10-Q · filed 2016-10-26 | 6.44M shares derived: average of 4 quarters · filed 2016-10-26 | ||||
| 2015-06-30 | 7.79M shares 10-Q · filed 2016-08-15 | 6.79M shares 10-Q · filed 2016-08-15 | 5.88M shares derived: average of 3 quarters · filed 2016-08-15 | 5.43M shares derived: average of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | 5.79M shares 10-Q · filed 2016-05-16 | 4.93M shares derived: average of 2 quarters · filed 2016-05-16 | 4.64M shares derived: average of 3 quarters · filed 2016-05-16 | 3.65M shares derived: average of 4 quarters · filed 2016-05-16 | ||||
| 2014-12-31 | 4.07M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | 4.06M shares derived: average of 2 quarters · filed 2016-03-21 | 2.94M shares derived: average of 3 quarters · filed 2016-03-21 | 2.26M shares 10-K · filed 2016-03-21 | ||||
| 2014-09-30 | 4.06M shares 10-Q · filed 2015-11-13 | 3.78M shares 10-Q · filed 2014-11-14 | 2.38M shares derived: average of 2 quarters · filed 2015-11-13 | 1.65M shares 10-Q · filed 2015-11-13 | 3.16M shares 10-Q · filed 2014-11-14 | 1.29M shares derived: average of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | 695.45K shares 10-Q · filed 2015-08-14 | 2.90M shares 10-Q · filed 2014-08-14 | 447.73K shares 10-Q · filed 2015-08-14 | 2.85M shares 10-Q · filed 2014-08-14 | 365.15K shares derived: average of 3 quarters · filed 2015-08-14 | 323.86K shares derived: average of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | 200.00K shares 10-Q · filed 2015-05-15 | 200.00K shares derived: average of 2 quarters · filed 2015-05-15 | 200.00K shares derived: average of 3 quarters · filed 2015-05-15 | 200.00K shares derived: average of 4 quarters · filed 2015-05-15 | ||||
| 2013-12-31 | 200.00K shares derived: 10-K 12 month − 10-K 9 month · filed 2015-03-27 | 200.00K shares derived: average of 2 quarters · filed 2015-03-27 | 200.00K shares derived: average of 3 quarters · filed 2015-03-27 | 200.00K shares 10-K · filed 2015-03-27 | ||||
| 2013-09-30 | 200.00K shares 10-K · filed 2015-03-27 | 2.67M shares 10-Q · filed 2014-11-14 | 200.00K shares derived: average of 2 quarters · filed 2015-03-27 | 200.00K shares 10-K · filed 2015-03-27 | 2.59M shares 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | 200.00K shares 10-K · filed 2015-03-27 | 2.59M shares 10-Q · filed 2014-08-14 | 200.00K shares 10-K · filed 2015-03-27 | 2.55M shares 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |